ZimVie (NASDAQ:ZIMV) Coverage Initiated by Analysts at B. Riley

Research analysts at B. Riley began coverage on shares of ZimVie (NASDAQ:ZIMV) in a note issued to investors on Thursday,Briefing.com Automated Import reports. The firm set a “buy” rating and a $16.00 price target on the stock. B. Riley’s price objective points to a potential upside of 77.29% from the stock’s previous close.

Separately, Needham & Company LLC reiterated a “hold” rating on shares of ZimVie in a research report on Wednesday.

ZimVie Price Performance

Shares of ZIMV stock traded down $0.58 during trading on Thursday, hitting $9.03. The company had a trading volume of 42,004 shares, compared to its average volume of 134,139. The firm has a market capitalization of $251.32 million, a P/E ratio of -0.69 and a beta of 2.14. ZimVie has a one year low of $8.56 and a one year high of $22.40. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.38 and a current ratio of 1.94. The stock’s 50-day moving average price is $12.16 and its 200 day moving average price is $13.59.

ZimVie (NASDAQ:ZIMV) last released its earnings results on Wednesday, February 26th. The company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.02. The company had revenue of $111.52 million for the quarter, compared to analyst estimates of $113.67 million. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. Equities analysts expect that ZimVie will post 0.6 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Wealth Enhancement Advisory Services LLC boosted its stake in shares of ZimVie by 5.8% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 15,127 shares of the company’s stock valued at $211,000 after purchasing an additional 836 shares in the last quarter. J. Goldman & Co LP boosted its position in ZimVie by 167.5% in the fourth quarter. J. Goldman & Co LP now owns 1,425,810 shares of the company’s stock valued at $19,890,000 after buying an additional 892,785 shares in the last quarter. Forest Hill Capital LLC grew its stake in shares of ZimVie by 25.9% during the fourth quarter. Forest Hill Capital LLC now owns 172,809 shares of the company’s stock worth $2,411,000 after buying an additional 35,500 shares during the last quarter. Deutsche Bank AG increased its holdings in shares of ZimVie by 61.7% during the fourth quarter. Deutsche Bank AG now owns 23,796 shares of the company’s stock worth $332,000 after buying an additional 9,084 shares in the last quarter. Finally, D. E. Shaw & Co. Inc. lifted its stake in shares of ZimVie by 12.1% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 301,316 shares of the company’s stock valued at $4,203,000 after acquiring an additional 32,551 shares during the last quarter. Institutional investors own 95.63% of the company’s stock.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.